Trials / Conditions / Dual Antiplatelet Therapy

Dual Antiplatelet Therapy

15 registered clinical trials studyying Dual Antiplatelet Therapy — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB NCT06535568	Fondazione Ricerca e Innovazione Cardiovascolare ETS	N/A
Recruiting	24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) NCT06014060	China National Center for Cardiovascular Diseases	N/A
Not Yet Recruiting	Efficacy and Safety of Shortening Dual Antiplatelet Therapy Duration with IVUS Guidance in PCI Patients NCT06648720	University Medical Center Ho Chi Minh City (UMC)	N/A
Recruiting	Ticagrelor-Based Dual Antiplatelet Therapy Duration in CABG NCT06981390	Kexiang Liu, MD	N/A
Not Yet Recruiting	OCT or Angiography Guided De-escalation of DAPT NCT06339021	Shenyang Northern Hospital	EARLY_Phase 1
Unknown	De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients W NCT05903976	Azienda Ospedaliera Universitaria Policlinico "G. Martino"	Phase 3
Completed	Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting NCT05380063	China National Center for Cardiovascular Diseases	Phase 4
Recruiting	Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI NCT05491200	Research Maatschap Cardiologen Rotterdam Zuid	Phase 4
Recruiting	Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery NCT06075433	Genoss Co., Ltd.	—
Recruiting	Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery NCT06075420	Genoss Co., Ltd.	—
Completed	Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Diseas NCT04824911	Chang Gung Memorial Hospital	Phase 2
Unknown	Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding R NCT03287167	Shanghai MicroPort Medical (Group) Co., Ltd.	Phase 4
Unknown	Ethnic Differences and the Ischemia/Bleeding Risk of DAPT Duration NCT03338335	Seoul National University Hospital	—
Unknown	Is There a Transient Rebound Effect of Platelet Reactivity Following Cessation of Dual Antiplatelet Therapy Wi NCT02808039	Rabin Medical Center	—
Completed	Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition NCT01582217	Icahn School of Medicine at Mount Sinai	—